Home  »  Business   »  What Do Analysts Say About Cullinan Oncology Inc. ...

What Do Analysts Say About Cullinan Oncology Inc. (CGEM)?

How have the shares performed?

Cullinan Oncology Inc. (CGEM) saw an uptrend of 8.38% in the recent trading with $30.77 being its most recent. The current price level -48.59% lower than the highest price of $59.85 marked by the stock while trading over the past 52-weeks, whereas it is 15.81% higher than the lowest price of $26.57 the company dropped to over past 52-weeks. The latest news story on CGEM appeared in GlobeNewswire under the title “Cullinan Oncology Announces Management Transition” on May-21-21.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Squeezing the time span to 30 day period shows us the stock is currently trading -15.42% below one month high and is +15.81% above of the lowest during that time. Looking into the simple moving average, Cullinan Oncology Inc. (CGEM)’s stock stands at a SMA-50 of $33.82 while that of 5-day is reading $29.05.

Do analysts rate it as a buy, sell or hold?

Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.00 for the stock.

Cullinan Oncology Inc. Earnings – What Happened With CGEM

Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Cullinan Oncology Inc. (CGEM) last released financial results for the quarter that ended 3/30/2021, posting a surprise factor of -100.00% for net revenue.

CGEM – Cullinan Oncology Inc. Stock Earnings Estimates

The perspective of Cullinan Oncology Inc. (NASDAQ:CGEM)’s current quarter earnings identifies that analysts are in consensus over the estimate of 0.06 for stock’s EPS in the current quarter. 2 analysts covering the stock at Wall Street were agreed upon that EPS consensus. Company’s EPS for the last quarter was 0.

Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 41.98 million. CGEM does have institutional investors; and they hold 72.00% of the stock.

Cullinan Oncology Inc. – Insider Activity and Holdings

As on Mar 30, 2021, MPM ONCOLOGY IMPACT MANAGEMENT LP was the top most holder in Cullinan Oncology Inc. (NASDAQ:CGEM) with an ownership of 7.91 million shares of the company or 18.19% of the stake worth $329.77 million. The filing also reveals Foresite Capital Management V, LLC as the second largest holder in the company with a control over 6.28% of the outstanding shares. Its stake is worth $113.82 million for having 2.73 million shares in hand.

CHI Advisors LLC also came holding a key position in the company during the recent quarter and it now holds 5.06% of the outstanding shares. With this there are now 92 institutions which have possession in CGEM’s shares.

Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 2.00 for the stock.

The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Cullinan Oncology Inc. has a debt to equity ratio of 0.00.

Technical Analysis of Cullinan Oncology Inc. (NASDAQ:CGEM) stock

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Leave a Comment

Your email address will not be published. Required fields are marked *

More Posts

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam